 |
Chairman, MdBio Division Douglas Doerfler President & Chief Executive Officer, MaxCyte |
|
Board Members |
||
 |
Scott Allocco President & Co-Founder BioMarker Strategies |
|
 |
William C. Bertrand Executive Vice President and General Counsel MedImmune |
|
 |
David Block President & CEO Gliknik, Inc. |
|
 |
Marco A. Chacon, Ph.D. President and Chief Executive Officer Paragon Bioservices, Inc. |
|
 |
Richard E. Chipkin, Ph.D. President and Chief Executive Officer Psyadon Pharmaceuticals |
|
 |
David M. Feitel Executive Vice President, General Counsel and Secretary Martek Biosciences Corporation |
|
 |
J.J. Finkelstein President & Chief Executive Officer RegeneRx Biopharmaceuticals, Inc. |
|
 |
Dennis Hansen President Shady Grove Adventist Hospital |
|
 |
Joe Hernandez |
|
 |
Stephen Hoffman, Ph.D. Chief Executive Officer Sanaria, Inc. |
|
 |
Robert House |
|
 |
W. James Jackson, Ph.D. Chief Scientific Officer Emergent Biosolutions, Inc. |
|
 |
Uplaksh Kumar, Ph.D. Director, Frederick Operations Life Technologies |
|
 |
Steven Meltzer Partner Pillsbury Winthrop Shaw Pittman, LLP |
|
 |
Carol Nacy Chief Executive Officer Sequella, Inc. |
|
 |
Carlos Orantes President and CEO AVANZA Laboratories |
|
 |
Jerry L. Parrott Vice President, Corporate Communications + Public Policy Human Genome Sciences, Inc. |
|
 |
Ellen Sheets, M.D. Chief Medical Officer/ Vice President Qiagen, Inc. |
|
 |
Brad Stewart President Cylex, Inc. |
|
